We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+0.9%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$105M
AUM Growth
+$62.5K
Cap. Flow
+$1.82M
Cap. Flow %
1.74%
Top 10 Hldgs %
25.71%
Holding
104
New
5
Increased
26
Reduced
40
Closed
4

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$670K
2
TROW icon
T. Rowe Price
TROW
+$665K
3
APLS
Apellis Pharmaceuticals
APLS
+$644K
4
GEHC icon
GE HealthCare
GEHC
+$575K
5
TFIN icon
Triumph Financial Inc
TFIN
+$546K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$640K
2
GE icon
GE Aerospace
GE
+$524K
3
GILD icon
Gilead Sciences
GILD
+$345K
4
ZION icon
Zions Bancorporation
ZION
+$270K
5
TRV icon
Travelers Companies
TRV
+$244K

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Financials 19.93%
3 Energy 16.63%
4 Industrials 13.42%
5 Consumer Discretionary 11.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
51
DraftKings
DKNG
$11.7B
$858K 0.82%
44,299
+1,720
+4% +$28.6K
WAL icon
52
Western Alliance Bancorporation
WAL
$9.04B
$830K 0.79%
23,360
-65
-0.3% -$3.98K
WY icon
53
Weyerhaeuser
WY
$18.2B
$783K 0.75%
25,982
– –
APLS
54
DELISTED
Apellis Pharmaceuticals
APLS
$737K 0.7%
+11,169
New +$644K
BAC icon
55
Bank of America
BAC
$437B
$720K 0.69%
25,170
+682
+3% +$22.5K
PEP icon
56
PepsiCo
PEP
$191B
$719K 0.69%
3,945
– –
CB icon
57
Chubb
CB
$134B
$711K 0.68%
3,664
-120
-3% -$25.2K
BF.A icon
58
Brown-Forman Class A
BF.A
$12.9B
$698K 0.67%
10,704
– –
HON icon
59
Honeywell
HON
$78.2B
$692K 0.66%
3,840
– –
BANR icon
60
Banner Corp
BANR
$2.4B
$690K 0.66%
12,697
– –
CVS icon
61
CVS Health
CVS
$134B
$667K 0.64%
8,970
-7,635
-46% -$640K
GEHC icon
62
GE HealthCare
GEHC
$31.5B
$661K 0.63%
+8,056
New +$575K
BX icon
63
Blackstone
BX
$108B
$655K 0.63%
7,454
– –
GD icon
64
General Dynamics
GD
$103B
$615K 0.59%
2,693
-20
-0.7% -$4.62K
CAT icon
65
Caterpillar
CAT
$382B
$572K 0.55%
2,500
– –
ABT icon
66
Abbott
ABT
$185B
$571K 0.55%
5,635
-105
-2% -$11.1K
ENB icon
67
Enbridge
ENB
$118B
$570K 0.54%
14,936
+125
+0.8% +$4.9K
ORCL icon
68
Oracle
ORCL
$409B
$561K 0.54%
6,040
– –
CL icon
69
Colgate-Palmolive
CL
$71.6B
$556K 0.53%
7,400
-50
-0.7% -$3.72K
MS icon
70
Morgan Stanley
MS
$332B
$551K 0.53%
6,273
– –
SM icon
71
SM Energy
SM
$7.66B
$498K 0.48%
17,670
– –
HD icon
72
Home Depot
HD
$339B
$495K 0.47%
1,678
– –
PACW
73
DELISTED
PacWest Bancorp
PACW
$484K 0.46%
49,740
+1,740
+4% +$38.7K
EPD icon
74
Enterprise Products Partners
EPD
$81.9B
$473K 0.45%
18,280
+50
+0.3% +$1.28K
HSY icon
75
Hershey
HSY
$35.7B
$471K 0.45%
1,850
– –
1 2
3
4 5

Similar funds

PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
CWR
Chico Wealth RIA Chico, California $164M AUM 24.86% 1-Year Est. Return
ACM
Alamar Capital Management Santa Barbara, California $164M AUM 19.77% 1-Year Est. Return
PWAM
Papamarkou Wellner Asset Management New York $164M AUM 25.23% 1-Year Est. Return
CCM
Clutterbuck Capital Management Cleveland, Ohio $164M AUM
GP
Gridiron Partners Wexford, Pennsylvania $164M AUM 3.31% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return

Sippican Capital Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Sippican Capital Advisors held 104 positions worth $105M, up 0.06% from $105M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sippican Capital Advisors's Q1 2023 filing shows 5 new, 26 increased, 40 reduced and 4 closed positions. Its largest new stake was Apellis Pharmaceuticals: 11,169 shares worth $737K. The largest sale was CVS Health, an estimated $640K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Energy.

  • Sippican Capital Advisors's largest Q1 2023 buy was Apellis Pharmaceuticals: 11,169 shares worth $737K.
  • Sippican Capital Advisors added most to 3M in Q1 2023, an estimated $670K increase.
  • Sippican Capital Advisors's biggest Q1 2023 reduction was CVS Health, cutting an estimated $640K.
  • Sippican Capital Advisors fully exited Zions Bancorporation in Q1 2023, selling an estimated $270K.
  • Sippican Capital Advisors's ten largest holdings make up 26% of its $105M portfolio in Q1 2023.
  • Sippican Capital Advisors opened 5 new positions and closed 4 in Q1 2023.
  • Sippican Capital Advisors's portfolio value rose 0.06% quarter-over-quarter to $105M.

Based on Sippican Capital Advisors's 13F filing for Q1 2023, filed 14 Jul 2023.